How Companies in Colombia Can Source Pharma Products & CDMO Services (2026 Guide)
Colombia • Source Pharma Products & CDMO Services
Introduction
Colombia has one of the larger pharmaceutical markets in Latin America, with an established local industry, a strong private distribution network and large institutional buyers in the health system. Even so, many APIs, specialty medicines and sterile products are imported, and local companies increasingly use contract manufacturers to extend their portfolios.
Every medicine sold in Colombia needs a registro sanitario from the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), and every foreign plant must meet INVIMA's GMP requirements. That makes supplier choice a regulatory decision as much as a commercial one.
This guide covers where supply comes from, what Colombian buyers typically source, how to qualify a supplier, the import documents you need, logistics into Colombian ports and the common problems with practical fixes. For background on demand and local players, see our Colombian pharmaceutical market overview.
Where supply comes from
Colombian buyers usually combine several supply bases rather than relying on one:
- India and China supply most generic APIs and a large share of finished generics, especially oral solids and antibiotics.
- Europe (EU-GMP) and the United States are the main sources for biologics, complex injectables, oncology and specialty products.
- Regional manufacturers in Brazil, Argentina and Mexico offer Spanish or Portuguese documentation, Zone IV stability data and shorter transit times. Colombia's own industry also supplies many oral and topical generics.
- Trade agreements with the Andean Community, the Pacific Alliance, the EU and the US can reduce duties when origin rules are met.
The right source depends on the product. Cost matters for high-volume generics, while for sterile and biologic products a supplier's inspection history and dossier quality matter far more.
Pharma categories supply
| Category | What Colombian buyers typically source |
|---|---|
| APIs | Generic APIs for local tablet, capsule and liquid manufacturing |
| Finished generics | Cardiovascular, diabetes, gastrointestinal, pain and respiratory medicines |
| Hospital products | Injectable antibiotics, anaesthetics, critical-care drugs, IV solutions |
| Oncology and biologics | Cytotoxics, monoclonal antibodies, biosimilars, insulin |
| Specialty dosage forms | Ophthalmics, inhalers, transdermals, prefilled syringes |
| CDMO and private label | Contract manufacturing, packaging, dossier development |
Local manufacturers often buy APIs with a supporting technical file, while importers and distributors look for finished products that can be registered quickly and labelled in Spanish.
How to source pharma products
1. Set out the requirement
Define the molecule, strength, dosage form, pack size, annual volume and channel: retail, health insurers (EPS), hospitals or public tenders. Note whether the product falls under price regulation.
2. Check GMP status
INVIMA must accept the GMP status of the foreign manufacturing site. Ask whether the plant already holds an INVIMA GMP certificate or a certificate from an authority INVIMA recognises, and verify it with the issuing authority. Our supplier verification guide explains what to check.
3. Review the technical file
Request the COPP, batch Certificates of Analysis, validation summaries, Zone IV long-term stability data and a CTD-format dossier. For generics, check what bioavailability or bioequivalence evidence INVIMA requires for that molecule.
4. Test samples and compare quotes
Compare at least three suppliers on unit price, MOQ, lead time, Incoterms and artwork support. Test samples in an accredited laboratory before committing.
5. Contract and register
Sign a supply and quality agreement covering specifications, change control and complaint handling, then file with INVIMA. You can reach several GMP-certified suppliers with one request through the PharmaTradz RFQ.
Required documents for import
For registration with INVIMA
- Legal documents for the owner, manufacturer and importer, apostilled where issued abroad
- GMP certificate accepted by INVIMA for each manufacturing site
- COPP or free sale certificate from the reference country
- Technical dossier with quality, stability and, where required, bioequivalence or clinical data
- Spanish label and package insert artwork
For each shipment
- Registro sanitario number shown on the import declaration
- INVIMA approval of the import request through the VUCE single window, where applicable
- Batch Certificate of Analysis
- Commercial invoice, packing list and bill of lading or air waybill
- Certificate of origin when claiming a trade preference
- Temperature records for cold-chain products
- FNE approval and quota for products containing controlled substances
Logistics and shipping
Main entry points
Sea cargo arrives mainly through Cartagena and Barranquilla on the Caribbean coast and Buenaventura on the Pacific, which is often used for cargo from Asia. El Dorado International Airport in Bogotá handles most pharmaceutical air cargo, with José María Córdova (Medellín) and Alfonso Bonilla Aragón (Cali) as alternatives.
Indicative transit times
| Origin | Sea freight | Air freight |
|---|---|---|
| Asia | Typically 4 to 7 weeks | Typically 4 to 8 days |
| Europe | Typically 2 to 4 weeks | Typically 2 to 5 days |
| Latin America and the US | Typically 1 to 2 weeks | Typically 1 to 3 days |
Cold chain, Incoterms and customs
Biologics, vaccines and insulin should travel with validated packaging and data loggers, and the inland leg to Bogotá needs the same care as the international leg. Many importers use FCA or FOB with their own forwarder for control over routing; smaller buyers often prefer CIP. Customs clearance is handled with DIAN, while INVIMA carries out health controls at points of entry, so registration details, batch numbers and labels must match the paperwork exactly.
Legal and regulatory overview
Regulator and registration
INVIMA, attached to the Ministry of Health and Social Protection, grants the registro sanitario. Chemically synthesised medicines and biologics follow separate rules, and biologics have their own evaluation pathway. The registration names the owner, manufacturer and importer, and foreign owners usually act through a local legal representative.
GMP and stability
INVIMA certifies GMP for foreign plants, either by inspection or, in defined cases, by recognising certificates from certain foreign authorities. Stability data must support Zone IV storage; confirm with INVIMA's current guidance which conditions apply.
Labelling and pricing
Labels and inserts must be in Spanish and carry the registro sanitario number. Some medicines fall under price regulation set by the national medicines pricing commission, so check the status of your molecule before pricing.
Unregistered and special routes
INVIMA can authorise imports of vital medicines that are not available in Colombia, for specific patients or groups. Controlled substances need approval from the Fondo Nacional de Estupefacientes (FNE). Public buyers publish tenders through the national procurement system. Our dossier and registration service can help with file preparation.
Common challenges and practical solutions
| Challenge | Practical solution |
|---|---|
| Foreign GMP not yet accepted by INVIMA | Check GMP status first and budget time for INVIMA certification if needed. |
| Dossier gaps | Run a gap analysis against INVIMA requirements before filing. |
| Stability data at the wrong conditions | Ask for Zone IV data up front, or plan new studies before registration. |
| Price-regulated molecules | Check the regulated price before agreeing purchase terms. |
| Delays at entry | Match invoice, label and registration details line by line before dispatch. |
| Cold-chain breaks inland | Use GDP-trained carriers for the port or airport to warehouse leg. |
Most delays come from avoidable mismatches between documents. A shared pre-shipment checklist with the supplier and forwarder solves many of them.
Conclusion
Colombian companies have good options across Asia, Europe, North America and Latin America. The best results come from matching each product to the right supply base, confirming that INVIMA will accept the manufacturing site, and preparing a dossier and stability package that fits Colombian rules from the start.
PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa, and can help you shortlist suppliers for APIs, finished products and contract manufacturing. Explore more resources on our Colombia hub.
Frequently Asked Questions
Who regulates medicines in Colombia?
INVIMA grants the registro sanitario for medicines and oversees GMP compliance, including for foreign manufacturing sites.
Does a foreign plant need INVIMA GMP approval?
Yes. INVIMA must accept the site's GMP status, either through its own certification or, in defined cases, by recognising certificates from certain foreign authorities.
Which ports are best for shipments into Colombia?
Cartagena and Barranquilla serve Caribbean routes, Buenaventura is common for cargo from Asia, and El Dorado in Bogotá handles most air cargo.
Can unregistered medicines be imported into Colombia?
Only in specific cases. INVIMA can authorise imports of vital medicines that are not available in the country, for particular patients or groups.
Are medicine prices regulated in Colombia?
Some are. The national pricing commission sets controls on certain medicines, so check your molecule before agreeing terms.
What is needed to import controlled substances?
Approval and a quota from the Fondo Nacional de Estupefacientes, requested through the VUCE single window, in addition to the INVIMA registration.
More on Colombia
Source Pharma Products & CDMO Services — other markets
Planning to register or source in Colombia?
Tell us the molecule, dosage form and target market. We will come back on the regulatory pathway and whether the project is realistic before you commit anything.
Submit a Requirement Ask a questionIf you already hold WHO-GMP, EU-GMP, USFDA or PIC/S approval, you are closer to supplying Colombia than you probably think.
Colombia's regulator publishes a register of authorised products. Look up any supplier's claims yourself — including ours.
